Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Monostory

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
British Journal of Pharmacology|March 28, 1998
Ipriflavone as an inhibitor of human cytochrome P450 enzymesK Monostory, L Vereczkey, F Lévai, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|September 25, 2003
Some aspects of interindividual variations in the metabolism of xenobioticsV Tamási, L Vereczkey, A Falus, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 31, 1998
Species differences in metabolism of panomifene, an analogue of tamoxifenK Monostory, K Jemnitz, L Vereczkey, et al.
Orvosi Hetilap|March 13, 2001
[About paracetamol again]E Hazai, K Monostory, A Bakos, et al.
European Journal of Drug Metabolism and Pharmacokinetics|June 26, 2001
The in vitro biosynthesis and stability measurement with agyl-glycuronide isoformes of the main metabolite of ipriflavoneK Jemnitz, F Lévai, K Monostory, et al.
Biochemical and Biophysical Research Communications|August 14, 2001
The effect of dexamethasone on P450 activities in regenerating rat liverV Tamási, Kiss A, O Dobozy, et al.
Transplantation Proceedings|September 15, 2012
Significance of mycophenolate monitoring in liver transplant recipients: toward the cut-off levelE Sarvary, B Nemes, M Varga, et al.
Transplantation Proceedings|August 10, 2010
Small difference in international normalized ratio may yield a significant impact on prioritizing patients listed for liver transplantationE Sarvary, Zs Seregely, J Fazakas, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
British Journal of Pharmacology|March 28, 1998
Ipriflavone as an inhibitor of human cytochrome P450 enzymesK Monostory, L Vereczkey, F Lévai, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|September 25, 2003
Some aspects of interindividual variations in the metabolism of xenobioticsV Tamási, L Vereczkey, A Falus, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 31, 1998
Species differences in metabolism of panomifene, an analogue of tamoxifenK Monostory, K Jemnitz, L Vereczkey, et al.
Orvosi Hetilap|March 13, 2001
[About paracetamol again]E Hazai, K Monostory, A Bakos, et al.
European Journal of Drug Metabolism and Pharmacokinetics|June 26, 2001
The in vitro biosynthesis and stability measurement with agyl-glycuronide isoformes of the main metabolite of ipriflavoneK Jemnitz, F Lévai, K Monostory, et al.
Biochemical and Biophysical Research Communications|August 14, 2001
The effect of dexamethasone on P450 activities in regenerating rat liverV Tamási, Kiss A, O Dobozy, et al.
Transplantation Proceedings|September 15, 2012
Significance of mycophenolate monitoring in liver transplant recipients: toward the cut-off levelE Sarvary, B Nemes, M Varga, et al.
Transplantation Proceedings|August 10, 2010
Small difference in international normalized ratio may yield a significant impact on prioritizing patients listed for liver transplantationE Sarvary, Zs Seregely, J Fazakas, et al.
Pageof 2